The DOI matches its Crossref record; 167 of the 168 references it cites were found in a registry or an index.
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Open accessAbstract
This article reviews cigarette smoking in patients with psychiatric disorders (PD) and substance use disorders (SUD). Rates of smoking are approximately 23% in the U.S. population but approximately twoto four‐fold higher in patients with PD and SUD. Many remaining smokers have had repeated smoking cessation failures, possibly due to the presence of co‐morbid PD and SUDs. There is modest, evidence‐based support for effective treatment interventions for nicotine addiction in PD and SUD. Further research is needed to increase our understanding of nicotine addiction in PD and SUD and develop more effective treatment interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, a large proportion of smokers report that they smoke to control symptoms of anxiety and depression (Picciotto et al. 2002), and the rate of smoking in individuals with affective disorders is more than double the rate in the general population (Kalman et al. 2005).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Kalman et al. 2005
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Cigarette smoking among adults — United States, 1988
Bachman, J. G., Johnston, L. D., & O’Malley, P. M. (1992) · Patient Education and Counseling · doi:10.1016/0738-3991(92)90149-d · Cited by 1,705
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
Adverse Childhood Experiences and Smoking During Adolescence and Adulthood
Anda, R. F. (1999) · JAMA · doi:10.1001/jama.282.17.1652 · Cited by 1,256
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Research works printed but not linked: 12
- George TP, 2001, Nicotine addiction and schizophrenia, Psychiatric Times, 18, 39
- 10.1037/0278-6133.17.1.56 · DOI
- 10.1037/0278-6133.18.1.14 · DOI
- Yang YK, 2002, Nicotine decreases bradykinesiarigidity in haloperidol‐treated patients with schizophenia, Neuropsychopharmacology, 27, 684
- 10.1037/0022-006X.61.5.761 · DOI
- Hughes JR, 1995, Alcohol and Tobacco: From Basic Science to Policy, 171
- 10.1037/1064-1297.9.1.91 · DOI
- 10.1037/1064-1297.7.1.64 · DOI
- 10.1037/0022-006X.62.1.141 · DOI
- George TP, 2002, Nicotine addiction and schizophrenia: a clinical approach, Primary Psychiatry, 9, 48
- 10.1037/0893-164X.18.1.78 · DOI
- 10.1001/jama.278.13.1087 · DOI
Cited by
Sorted by citations
Items 301–400 of 594
Mental Health Correlates of Cigarette Use in LGBT Individuals in the Southeastern United States
Drescher, C. F., Lopez, E. J., Griffin, J. A., Toomey, T. M., Eldridge-Smith, E. D., & Stepleman, L. M. (2018) · Substance Use & Misuse · doi:10.1080/10826084.2017.1418087 · Cited by 14
Fine, D. R., Bearnot, B. I., Rigotti, N. A., & Baggett, T. P. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.05.004 · Cited by 13
Arbour‐Nicitopoulos, K. P., Faulkner, G., Cohn, T. A., & Selby, P. L. (2010) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2010.05.006 · Cited by 14
Dealing with tobacco use and dependence within primary health care: time for action
Vardavas, C. I., Symvoulakis, E. K., & Lionis, C. D. (2013) · Tobacco Induced Diseases · doi:10.1186/1617-9625-11-6 · Cited by 13
The indirect effect of panic disorder on smoking cognitions via difficulties in emotion regulation
Yang, M.-J., Zvolensky, M. J., & Leyro, T. M. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.03.021 · Cited by 12
Han, B. H., Sherman, S. E., Link, A. R., Wang, B., & McNeely, J. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.05.014 · Cited by 13
Okoli, C. T. C., Otachi, J. K., Manuel, A., & Woods, M. A. (2017) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12435 · Cited by 13
Comorbidities: Psychiatric, Medical, Medications, and Substances
Barczi, S. R., & Juergens, T. M. (2006) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.04.001 · Cited by 13
Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mhmb.061314 · Cited by 12
Ketamine induces hyperactivity in rats and hypersensitivity to nicotine in rat striatal slices
Rodvelt, K. R., Kracke, G. R., Schachtman, T. R., & Miller, D. K. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.06.012 · Cited by 12
Smoking is a predictor of depression onset among National Guard soldiers
Goodwin, R. D., Prescott, M. R., Tamburrino, M., Calabrese, J. R., Liberzon, I., & Galea, S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.11.025 · Cited by 14
John, G., Pasche, S., Rothen, N., Charmoy, A., Delhumeau, C., & Genné, D. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003304 · Cited by 12
Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services
Koch, J. R., & Breland, A. B. (2015) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-015-9477-4 · Cited by 12
Rabin, R. A., Dermody, S. S., & George, T. P. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.12.017 · Cited by 12
Self-citationTae, H., Huh, H. J., Hwang, J., & Chae, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.058 · Cited by 12
Mizoguchi, H., Wang, T., Kusaba, M., Fukumoto, K., & Yamada, K. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.06.016 · Cited by 12
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
Effects of Topiramate on Smoking in Patients With Schizoaffective Disorder, Bipolar Type
Weinberger, A. H., George, T. P., Perkins, K. A., & Chengappa, K. N. R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816740cf · Cited by 12
Self-citationCohn, A. M., Cobb, C. O., Hagman, B. T., Cameron, A., Ehlke, S. J., & Mitchell, J. N. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.12.012 · Cited by 12
Goodman, M. S., Bridgman, A. C., Rabin, R. A., Blumberger, D. M., Rajji, T. K., Daskalakis, Z. J., George, T. P., & Barr, M. S. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.11.004 · Cited by 12
Self-citationMcLeish, A. C., Zvolensky, M. J., Marshall, E. C., & Leyro, T. M. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e3181961683 · Cited by 12
Stepankova, L., Kralikova, E., Zvolska, K., Kmetova, A., Blaha, M., Bortlicek, Z., Sticha, M., Anders, M., Schroeder, D. R., & Croghan, I. T. (2013) · Preventing Chronic Disease · doi:10.5888/pcd10.130051 · Cited by 11
Keizer, I., Gex‐Fabry, M., Bruegger, A., Croquette, P., & Khan, A. N. (2013) · International Journal of Mental Health Nursing · doi:10.1111/inm.12030 · Cited by 11
Weiss, S. T., Veach, L. J., McGill, W., & Brent, J. A. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2117052 · Cited by 13
Kelly, M. M., Latta, R. E., & Gimmestad, K. D. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.670846 · Cited by 11
Clinicians’ Perceptions of Implementation Extensiveness of 100% Tobacco Free Practices
Eby, L. T. D. T., & Laschober, T. C. (2013) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-013-9319-1 · Cited by 11
Agosti, V., & LEVIN, F. R. (2008) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0407-0 · Cited by 11
Pain-related anxiety and smoking processes: The explanatory role of dysphoria
Smit, T., Peraza, N., Garey, L., Langdon, K. J., Ditre, J. W., Rogers, A. H., Manning, K. F., & Zvolensky, M. J. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.008 · Cited by 12
Sex Differences in Graphic Warning Label Ratings by Addictions Clients
CAMPBELL, B. K., Le, T. L., Yip, D., Griffin, K. B., Gubner, N. R., & Guydish, J. R. (2018) · Tobacco Regulatory Science · doi:10.18001/trs.5.1.1 · Cited by 11
Stein, J. A., Zane, J. I., & Grella, C. E. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.647470 · Cited by 10
Minian, N., Noormohamed, A., Baliunas, D. O., Zawertailo, L. A., Mulder, C., Ravindran, A. V., de Oliveira, C., & Selby, P. L. (2018) · JMIR Research Protocols · doi:10.2196/resprot.9715 · Cited by 10
Mitkin, N. A., Unguryanu, T. N., Malyutina, S. K., & Kudryavtsev, A. V. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042905 · Cited by 10
Smoking Cessation for Those Pursuing Recovery from Substance Use Disorders
Derefinko, K. J., García, F. I. S., & Sumrok, D. D. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.014 · Cited by 10
Okoli, C. T. C., Al‐Mrayat, Y. D., Shelton, C. I., & Khara, M. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.06.005 · Cited by 10
Kathuria, H., Seibert, R. G., Cobb, V., Weinstein, Z., Gowarty, M. A., Helm, E. D., & Wiener, R. S. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000503 · Cited by 10
Acartürk, C., Nierkens, V., Agyemang, C. O., & Stronks, K. (2011) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-6-5 · Cited by 10
Dahne, J., Hoffman, E. M., & MacPherson, L. (2014) · Substance Use & Misuse · doi:10.3109/10826084.2014.958856 · Cited by 10
Stress and the ?7 Nicotinic Acetylcholine Receptor
Hunter, R. G. (2012) · Current Drug Targets · doi:10.2174/138945012800398982 · Cited by 10
Smoking cessation interventions for smokers with current or past depression
van der Meer, R. M., Willemsen, M. C., Smit, F., & Cuijpers, P. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006102 · Cited by 10
Fanne, R. A., Lidawi, G., Maraga, E., Moed, M., Roguin, A., & Meisel, S.-R. (2022) · Vaccines · doi:10.3390/vaccines10122116 · Cited by 9
Validity of self‐reported smoking in schizophrenia patients
Takeuchi, T., Nakao, M., Shinozaki, Y., & Yano, E. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02082.x · Cited by 9
Masuhara, J. E., Heah, T., & Okoli, C. T. C. (2013) · The Journal of Smoking Cessation · doi:10.1017/jsc.2013.17 · Cited by 9
Hughes, J. R., & Weiss, R. D. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02561.x · Cited by 9
Desire to Quit Smoking in an Outpatient Population of Persons with Serious Mental Illness
Carstens, C. A., & Linley, J. V. (2020) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-020-09698-1 · Cited by 9
Views and Attitudes of Patients in Mental Facilities Regarding Smoking
Κourakos, M., Kalokairinou, A., Zyga, S., & Koukia, E. (2015) · Global Journal of Health Science · doi:10.5539/gjhs.v8n8p228 · Cited by 9
Rodrigues, M., Stranges, S., Ryan, B. L., & Anderson, K. K. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02157-y · Cited by 9
NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices
Rodvelt, K. R., Schachtman, T. R., Kracke, G. R., & Miller, D. K. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.106 · Cited by 9
Differences in Cigarette Smoking Behaviors Among Heroin Inhalers Versus Heroin Injectors
Liu, S., Zhou, W., Zhang, J. H., Wang, Q., Xu, J., & Gui, D. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr115 · Cited by 9
Smoking Cessation Outcomes among Individuals with Substance Use and/or Psychiatric Disorders
Khara, M., & Okoli, C. T. C. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000115 · Cited by 9
Ineffectiveness of nicotinic acetylcholine receptor antagonists for treatment-resistant depression
Wang, H. R., Woo, Y. S., & Bahk, W. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000128 · Cited by 9
Peles, E., Sason, A., Schreiber, S., & Adelson, M. (2017) · American Journal on Addictions · doi:10.1111/ajad.12508 · Cited by 9
Staudt, J., Kok, T., de Haan, H., Walvoort, S. J. W., & Egger, J. I. M. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s424017 · Cited by 9
Li, Y., Hou, C., Ma, X.-R., Zang, Y., Jia, F., Zhong, B., Lin, Y.-Q., Chiu, H. F. K., Ungvari, G. S., Himelhoch, S. S., et al. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.10.003 · Cited by 8
Boozary, L. K., Frank-Pearce, S. G., Alexander, A. C., Sifat, M. S., Kurien, J., Waring, J. J. C., Ehlke, S. J., Businelle, M. S., Ahluwalia, J. S., & Kendzor, D. E. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100117 · Cited by 9
Jafry, M. Z., Martinez, J., Chen, T. A., Britton, M., Leal, I. M., Rogova, A., Kyburz, B., Williams, T., Patel, M., Carter, B. J., et al. (2023) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2023.100493 · Cited by 8
Cohn, A. M., Zhou, Y., Cha, S., Perreras, L., & Graham, A. L. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.11.001 · Cited by 9
Naudé, G. P., Strickland, J. C., Reed, D. D., & Amlung, M. T. (2021) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000469 · Cited by 11
Wood, C. M., & Vindel, A. C. (2009) · Psychosocial Intervention · doi:10.5093/in2009v18n3a3 · Cited by 7
Okoli, C. T. C., & Khara, M. (2013) · Community Mental Health Journal · doi:10.1007/s10597-013-9691-6 · Cited by 8
Neurocognitive Effects of Nicotine and Tobacco in Individuals with Schizophrenia
Weinberger, A. H., Creeden, C. L., Sacco, K. A., & George, T. P. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_06 · Cited by 8
Self-citationMistler, L. A., Brunette, M. F., Ferron, J. C., & Ziedonis, D. M. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.671093 · Cited by 8
Blankers, M., Buisman, R. S. M., Hopman, P., van Gool, R., & van Laar, M. (2016) · Tobacco Induced Diseases · doi:10.1186/s12971-016-0096-5 · Cited by 9
Gass, J. C., Morris, D. H., Winters, J. J., VanderVeen, J. W., & Chermack, S. T. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.10.006 · Cited by 9
Swalve, N. L., Barrett, S. T., Bevins, R. A., & Li, M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.043 · Cited by 8
Toikumo, S., Jennings, M. V., Pham, B. K., Lee, H., Mallard, T. T., Bianchi, S. B., Meredith, J. J., Vilar‐Ribó, L., Xu, H., Hatoum, A. S., et al. (2023) · medRxiv · doi:10.1101/2023.03.27.23287713 · Cited by 8
Manhapra, A., & Rosenheck, R. A. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000311 · Cited by 7
Keyser‐Marcus, L., Vassileva, J., Stewart, K., & Johns, S. E. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1287190 · Cited by 7
Rhodes, B. E., & Gottfredson, N. C. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106358 · Cited by 7
An initial investigation of the relationships between hoarding and smoking
Raines, A. M., Unruh, A. S., Zvolensky, M. J., & Schmidt, N. B. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.01.001 · Cited by 7
A manic episode in a 64-year-old man: an adverse effect of varenicline
Ahmed, A. I. A. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.11.005 · Cited by 7
Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders.
Morissette, S. B., Gulliver, S. B., Kamholz, B. W., Spiegel, D. A., Tiffany, S. T., & Barlow, D. H. (2012) · Psychology of Addictive Behaviors · doi:10.1037/a0028828 · Cited by 7
Self-citationAlosaimi, F. D., Abalhassan, M. F., Alhaddad, B., Fallata, E. O., Alhabbad, A. A., Alshenqiti, R., & Alassiry, M. Z. (2018) · International Journal of Mental Health Systems · doi:10.1186/s13033-018-0201-7 · Cited by 7
Jackson, M. A., Brown, A. L., Baker, A., Gould, G. S., & Dunlop, A. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032330 · Cited by 7
Han, S. Y., Cho, M. J., Won, S., Hong, J. P., Bae, J. N., Cho, S., Park, J., Lee, J., Jeon, H. J., & Chang, S. M. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.3.316 · Cited by 7
Cohn, A. M. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.03.001 · Cited by 7
Epigenetic and genetic profiling of comorbidity patterns among substance dependence diagnoses
Pathak, G. A., Pietrzak, R. H., Lacobelle, A., Overstreet, C. M., Wendt, F. R., Deak, J. D., Friligkou, E., Nuñez, Y. Z., Montalvo‐Ortiz, J. L., Levey, D. F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03031-y · Cited by 5
Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists for Smoking Cessation
Hendershot, C. S., Simmons, W. K., Jha, M. K., McKee, S. A., & Yammine, L. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.04.002 · Cited by 6
Nieto, S. J., Venegas, A., Burnette, E. M., MacKillop, J., & Ray, L. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05993-7 · Cited by 6
Holt, A. G., Hussong, A. M., Castro, M. G., Fedoriw, K. B., Schmidt, A. M., Prentice, A. N., & Ware, O. D. (2024) · Tobacco Use Insights · doi:10.1177/1179173x241254803 · Cited by 6
Predictors of Multiple Substance Use in Alcohol Dependence: The Role of Personality
Novais, F., & Pombo›, S. (2015) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000258 · Cited by 6
Aslam, A., Rather, S. P., Hussain, A., Younus, F., Saqib, N. U., & Hassan, I. (2022) · Indian Dermatology Online Journal · doi:10.4103/idoj.idoj_743_21 · Cited by 6
Woisard, K., Steinberg, J. L., Ma, L., Zuniga, E. A., Lennon, M., & Moeller, F. G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1117817 · Cited by 8
Bruckner, T. A., Yoon, J., & Gonzales, M. (2016) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-016-0722-9 · Cited by 7
Weg, M. W. V., Mengeling, M. A., Booth, B. M., Torner, J. C., & Sadler, A. G. (2015) · Medical Care · doi:10.1097/mlr.0000000000000285 · Cited by 6
Deng, H., Wang, J., Zhang, X., Ma, M., Domingo, C. B., Sun, H., & Kosten, T. R. (2016) · American Journal on Addictions · doi:10.1111/ajad.12337 · Cited by 6
Zugno, A. I., Oliveira, M. B., Mastella, G. A., Heylmann, A. S. A., Canever, L., Pacheco, F. D., Damazio, L. S., Citadin, S. A., de Lucca, L. A., Simões, L. R., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.010 · Cited by 6
Kelly, P. J., Townsend, C., Osborne, B. A., Baker, A., Deane, F. P., Keane, C. A., Ingram, I., & Lunn, J. (2018) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1442951 · Cited by 6
Reeves, L. E., Gaudiano, B. A., Metrik, J., Holst, C. G., Morena, A., Sydnor, V. J., Weinstock, L. M., & Epstein-Lubow, G. P. (2018) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1470359 · Cited by 6
Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States.
Gormley, M., Blondino, C. T., Taylor, D., Lowery, E., Clifford, J., Burkart, B., Graves, W., Prom-Wormley, E., & Lu, J. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa009 · Cited by 6
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 8
Mecamylamine for Treatment of People With Dual Diagnoses of Depression and Alcohol Dependence
Ralevski, E., Jane, J. S., O’Brien, E. M., Edens, E. L., Arnaout, B., Kerfoot, K. E., Keegan, K. A., Weiner, J., Russo, M., & Petrakis, I. L. (2013) · Journal of Dual Diagnosis · doi:10.1080/15504263.2013.835163 · Cited by 6
Ashor, A. W. (2013) · Journal of Young Pharmacists · doi:10.1016/j.jyp.2013.06.004 · Cited by 6
Tabagisme et comorbidités psychiatriques
Dervaux, A., & Laqueille, X. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.03.011 · Cited by 6
Cognitive behavioral therapy treatment for smoking alcoholics in outpatients
Guimarães, F. L., Nardi, A. E., Cardoso, A., Valença, A. M., da Conceição, E. G., & King, A. L. S. (2014) · Medical Express · doi:10.5935/medicalexpress.2014.06.08 · Cited by 6
Smoking Cessation Among Persons With Co-Occurring Substance Use Disorder and Mental Illness
Okoli, C. T. C., & Khara, M. (2011) · The Journal of Smoking Cessation · doi:10.1375/jsc.6.1.58 · Cited by 6
Moving Forward in Smoking Cessation: Issues for Psychiatric Nurses
Schroeder, S. A. (2009) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390308330843 · Cited by 6
Lim, C. C. W., Sun, T., Lai, G., Hall, W., Connor, J. P., Lee, Y. Y., & Cho, A. (2025) · Addiction · doi:10.1111/add.70281 · Cited by 5
Okoli, C. T. C., Torchalla, I., & Khara, M. (2011) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2011.01847.x · Cited by 5
Translational dynamics of alcohol tolerance of preclinical models and human laboratory studies.
Haass‐Koffler, C. L., Cannella, N., & Ciccocioppo, R. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000366 · Cited by 5
Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
Kowalec, K., Carney, H., Patel, M., Hitchon, C. A., Bolton, J. M., Patten, S. B., Graff, L. A., Bernstein, C. N., PESCHKEN, C. A., & Marrie, R. A. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11339 · Cited by 5
Metadata
- Authors
- Kalman, D., Morissette, S. B., & George, T. P.
- Affiliations
- Boston University (US)
- Yale University (US)
- Corresponding author
- George, Tony P.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2005-03-04
- Volume
- 14
- Issue
- 2
- Pages
- 106-123
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- PMC
- PMC1199553
- OpenAlex
- W2109605442
- Cited by
- 594
- References
- 168
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 11 · 2023: 20 · 2022: 26 · 2021: 19 · 2020: 44 · 2019: 20 · 2018: 37 · 2017: 32 · 2016: 38 · 2015: 32 · 2014: 36 · 2013: 43 · 2012: 35
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal on Addictions (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01-DA-1-4039, R01 DA15757, R29-DA-11713, R01-DA-1-3672, R01DA013672, R01DA015757, R29DA011713, K23DA016376, K02-DA-16611, R01DA014039, K23-DA-16376, K02DA016611)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- cigarette smoking, mental illness, substance use disorders, comorbidities, nicotine dependence, smoking cessation, tobacco dependence treatment
- MeSH terms
- Mental Disorders, Forecasting, Humans, Smoking, Time Factors, United States, Comorbidity, Diagnosis, Dual (Psychiatry), Neurotransmitter Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review